ÂÜÀòÂÒÂ×

The Leadership Team at Epsilogen is responsible for setting the strategic direction of the company, overseeing research and development efforts in immunoglobulin (IgE) antibodies for cancer treatment. They collaborate to drive innovation, ensure effective product development, and navigate the organization toward achieving its mission of revolutionizing cancer therapies. With a focus on leveraging IgE's unique properties, the team works to enhance clinical outcomes and accelerate the path to market.